
Insmed Incorporated – LSE:0JAV.L
Insmed Incorporated stock price today
Insmed Incorporated stock price monthly change
Insmed Incorporated stock price quarterly change
Insmed Incorporated stock price yearly change
Insmed Incorporated key metrics
Market Cap | 12.53B |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | -5.23 |
Revenue | 315.49M |
EBITDA | -671.57M |
Income | -746.89M |
Revenue Q/Q | 15.77% |
Revenue Y/Y | 22.53% |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | -212.87% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeInsmed Incorporated stock price history
Insmed Incorporated stock forecast
Insmed Incorporated financial statements
Jun 2023 | 77.22M | -244.80M | -316.99% |
---|---|---|---|
Sep 2023 | 79.07M | -158.93M | -201% |
Dec 2023 | 83.69M | -186.06M | -222.31% |
Mar 2024 | 75.5M | -157.09M | -208.07% |
2025 | 518.79M | -554.38M | -106.86% |
---|---|---|---|
2026 | 903.93M | -310.62M | -34.36% |
2027 | 1.49B | 30.71M | 2.06% |
2028 | 2.12B | 380.57M | 17.88% |
Analysts Price target
Financials & Ratios estimates
Jun 2023 | 1439139000 | 1.59B | 110.82% |
---|---|---|---|
Sep 2023 | 1324873000 | 1.61B | 121.84% |
Dec 2023 | 1329837000 | 1.66B | 124.96% |
Mar 2024 | 1159095000 | 1.62B | 140.1% |
Jun 2023 | -122.79M | -274.15M | 44.32M |
---|---|---|---|
Sep 2023 | -136.33M | 7.14M | 1.24M |
Dec 2023 | -130.81M | 1.80M | 123.26M |
Mar 2024 | -184.03M | 295.32M | 3.02M |
Insmed Incorporated alternative data
Aug 2023 | 736 |
---|---|
Sep 2023 | 736 |
Oct 2023 | 736 |
Nov 2023 | 736 |
Dec 2023 | 736 |
Jan 2024 | 736 |
Feb 2024 | 736 |
Mar 2024 | 912 |
Apr 2024 | 912 |
May 2024 | 912 |
Jun 2024 | 912 |
Jul 2024 | 912 |
Insmed Incorporated other data
Patent |
---|
Grant Filling date: 15 Jul 2020 Issue date: 20 Sep 2022 |
Grant Filling date: 24 Sep 2020 Issue date: 26 Jul 2022 |
Application CERTAIN (2S)-N-[(1S)-1-CYANO-2-PHENYLETHYL]-1,4-OXAZEPANE-2-CARBOXAMIDES FOR TREATING BRONCHIECTASIS Filling date: 14 Jan 2022 Issue date: 5 May 2022 |
Application Filling date: 9 Sep 2021 Issue date: 5 May 2022 |
Application Filling date: 20 Nov 2019 Issue date: 27 Jan 2022 |
Application Filling date: 20 Nov 2019 Issue date: 16 Dec 2021 |
Grant Filling date: 21 May 2019 Issue date: 19 Oct 2021 |
Application Filling date: 26 Feb 2021 Issue date: 9 Sep 2021 |
Application CERTAIN (2S)-N-[(1S)-1-CYANO-2-PHENYLETHYL]-1,4-OXAZEPANE-2-CARBOXAMIDES FOR TREATING INFLAMMATORY BOWEL DISEASE Filling date: 16 Jul 2019 Issue date: 19 Aug 2021 |
Application Filling date: 24 Sep 2020 Issue date: 29 Jul 2021 |
-
What's the price of Insmed Incorporated stock today?
One share of Insmed Incorporated stock can currently be purchased for approximately $26.33.
-
When is Insmed Incorporated's next earnings date?
Unfortunately, Insmed Incorporated's (0JAV.L) next earnings date is currently unknown.
-
Does Insmed Incorporated pay dividends?
No, Insmed Incorporated does not pay dividends.
-
How much money does Insmed Incorporated make?
Insmed Incorporated has a market capitalization of 12.53B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 24.39% to 305.21M US dollars.
-
What is Insmed Incorporated's stock symbol?
Insmed Incorporated is traded on the LSE under the ticker symbol "0JAV.L".
-
What is Insmed Incorporated's primary industry?
Company operates in the Healthcare sector and Medical - Pharmaceuticals industry.
-
How do i buy shares of Insmed Incorporated?
Shares of Insmed Incorporated can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Insmed Incorporated have?
As Jul 2024, Insmed Incorporated employs 912 workers.
-
When Insmed Incorporated went public?
Insmed Incorporated is publicly traded company for more then 7 years since IPO on 29 Jan 2018.
-
What is Insmed Incorporated's official website?
The official website for Insmed Incorporated is insmed.com.
-
Where are Insmed Incorporated's headquarters?
Insmed Incorporated is headquartered at 700 US Highway 202/206, Bridgewater, NJ.
-
How can i contact Insmed Incorporated?
Insmed Incorporated's mailing address is 700 US Highway 202/206, Bridgewater, NJ and company can be reached via phone at +90 89779900.
Insmed Incorporated company profile:

Insmed Incorporated
insmed.comLSE
912
Medical - Pharmaceuticals
Healthcare
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary arterial hypertension and other rare pulmonary disorders. Insmed Incorporated was founded in 1988 and is headquartered in Bridgewater, New Jersey.
Bridgewater, NJ 08807
:
ISIN: US4576693075
: